Fig. 3From: Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumoniaSlope of FVC % predicted for 2Â years after SLB. BAL bronchoalveolar lavage, FVC forced vital capacity, SLB surgical lung biopsy. For patients treated with anti-inflammatory drugs, patients with BAL lymphocytosis show a higher slope of FVC % predicted than patients without BAL lymphocytosis (a). On the other hand, limited to patients without anti-inflammatory drugs, no difference is evident between the groups (b)Back to article page